Glide Pharma is working with a number of both large and small pharmaceutical partners who want to investigate the delivery of their proprietary molecules with the Glide SDI. Typically, investigations are carried out initially under a feasibility agreement during which a suitable range of formulations are prepared and tested in vitro before embarking on in-vivo testing.
Whether you are looking for enhanced stability, improving the solubility of a poorly soluble drug, controlled release or just a better delivery system for your product in order to improve patient compliance then contact management_team@glidepharma.com for further information on how you can work with Glide Pharma.
